<VariationArchive VariationID="1456430" VariationName="NC_000002.11:g.(?_145153959)_(145158894_?)del" VariationType="Deletion" Accession="VCV001456430" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1458369" VariationID="1456430">
      <GeneList>
        <Gene Symbol="ZEB2" FullName="zinc finger E-box binding homeobox 2" GeneID="9839" HGNC_ID="HGNC:14881" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="144384081" stop="144520119" display_start="144384081" display_stop="144520119" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="145141941" stop="145277957" display_start="145141941" display_stop="145277957" Strand="-" />
          </Location>
          <OMIM>605802</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ZEB2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ZEB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_145153959)_(145158894_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="145153959" innerStop="145158894" display_start="145153959" display_stop="145158894" variantLength="4936" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_145153959)_(145158894_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_145153959)_(145158894_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_145153959)_(145158894_?)del AND Mowat-Wilson syndrome" Accession="RCV001972384" Version="7">
        <ClassifiedConditionList TraitSetID="1308">
          <ClassifiedCondition DB="MedGen" ID="C1856113">Mowat-Wilson syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1308" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2968" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mowat-Wilson syndrome</ElementValue>
                <XRef ID="Mowat-Wilson+syndrome/4895" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009341" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, microcephaly, and distinct facial features with or without Hirschsprung disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hirschsprung disease mental retardation syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ZEB2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MOWS</ElementValue>
                <XRef Type="MIM" ID="235730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9673" />
                <XRef ID="9673" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mowat-Wilson syndrome (MWS) is characterized by distinctive facial features (widely spaced eyes, broad eyebrows with a medial flare, low-hanging columella, prominent or pointed chin, open-mouth expression, and uplifted earlobes with a central depression), congenital heart defects with predilection for abnormalities of the pulmonary arteries and/or valves, Hirschsprung disease or chronic constipation, genitourinary anomalies (particularly hypospadias in males), and hypogenesis or agenesis of the corpus callosum. Most affected individuals have moderate-to-severe intellectual disability. Speech is typically limited to a few words or is absent, with relative preservation of receptive language skills. Growth restriction with microcephaly and seizure disorder are also common. Most affected people have a happy demeanor and a wide-based gait that can sometimes be confused with Angelman syndrome.</Attribute>
                <XRef ID="NBK1412" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301585</ID>
                <ID Source="BookShelf">NBK1412</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21343952</ID>
              </Citation>
              <XRef ID="2152" DB="Orphanet" />
              <XRef ID="C1856113" DB="MedGen" />
              <XRef ID="MONDO:0009341" DB="MONDO" />
              <XRef Type="MIM" ID="235730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4265189" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_014795.3_2_Deletion (exons 7-9)|MedGen:C1856113" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002240564" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ZEB2 protein in which other variant(s) (p.His1066Glnfs*56) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with ZEB2-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 7-9 of the ZEB2 gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ZEB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_145153959)_(145158894_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856113" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4265189" TraitType="Disease" MappingType="XRef" MappingValue="C1856113" MappingRef="MedGen">
        <MedGen CUI="C1856113" Name="Mowat-Wilson syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

